The FDA has taken a major step toward approving Palforzia, a treatment for peanut allergy that may reduce both the number and severity of allergic reactions. The treatment, assuming it ultimately gets approval, would be for allergy sufferers ages 4 to 17 who have been diagnosed with peanut allergy. Palforzia is a biologic oral immunotherapy (OIT) that received Fast Track … Continue readingSource: https://www.slashgear.com/the-fda-hasnt-approved-a-peanut-allergy-treatment-yet-but-its-close-14591704/
Droolin’ Dog sniffed out this story and shared it with you.
The Article Was Written/Published By: Brittany A. Roston
! #Headlines, #FDA, #Health, #Healthcare, #Medicine, #TechNews, #Newsfeed, #syndicated, news
No comments:
Post a Comment